I write about healthcare policy, with an emphasis on Rx drugs. President Biden signed the Inflation Reduction Act into law on August 16th, 2022. The IRA is the nation’s largest climate ...
Home Energy Rebates funding should start flowing to many consumers within months after the Department of Energy approved the ...
Here’s what’s included in the Inflation Reduction Act and what it can mean for you and your taxes. Today the President signed the Inflation Reduction Act of 2022 into law, which includes new ...
You may have heard about the Inflation Reduction Act (IRA), a sweeping piece of legislation signed in the last two years, designed to address some of the significant issues that the U.S. is facing.
The Inflation Reduction Act was signed into law in the summer of 2022 as part of President Biden’s Investing in America Agenda. This landmark legislation is helping small businesses and working ...
The Inflation Reduction Act was signed into law on August 16, 2022. For more information from Kiplinger about this climate, healthcare and tax legislation, see: 'Instant' EV Tax Credits Are a Hit ...
Biden signed the $750 billion health care ... who was previously a holdout on the legislation, and called it the Inflation Reduction Act, helping to clear the way for its passage in the Democratic ...
Discover the impact of the Inflation Reduction Act on generic drugs, benefiting certain stocks in the pharmaceutical sector.
President Joe Biden on Tuesday signed the Inflation Reduction Act (IRA) into law, providing billions of dollars to reduce medical and energy costs for millions of Americans. “In this historic ...
It’s why President Biden’s Inflation Reduction Act, signed into law one year ago, outlines a unique path for our prosperity—a path not dictated by big corporations or special interests but ...
On August 16, President Biden signed the Senate budget reconciliation package known as the Inflation Reduction Act of 2022 (“IRA”), which was approved by the U.S. House of Representatives on ...
President Biden announced the first batch of drugs designated for Medicare price negotiations that would make them more affordable for older and disabled Americans. But drug manufacturers are ...